SG76892G - Phospholipid composition - Google Patents

Phospholipid composition

Info

Publication number
SG76892G
SG76892G SG768/92A SG76892A SG76892G SG 76892 G SG76892 G SG 76892G SG 768/92 A SG768/92 A SG 768/92A SG 76892 A SG76892 A SG 76892A SG 76892 G SG76892 G SG 76892G
Authority
SG
Singapore
Prior art keywords
phospholipid composition
phospholipid
composition
Prior art date
Application number
SG768/92A
Other languages
English (en)
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of SG76892G publication Critical patent/SG76892G/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J7/00Phosphatide compositions for foodstuffs, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/829Liposomes, e.g. encapsulation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984Microcapsule with fluid core [includes liposome]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG768/92A 1986-11-28 1992-07-28 Phospholipid composition SG76892G (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US93591986A 1986-11-28 1986-11-28
US93856386A 1986-12-05 1986-12-05
US11957287A 1987-11-17 1987-11-17
PCT/US1987/003131 WO1988003797A1 (en) 1986-11-28 1987-11-25 Phospholipid composition

Publications (1)

Publication Number Publication Date
SG76892G true SG76892G (en) 1992-10-02

Family

ID=27382333

Family Applications (1)

Application Number Title Priority Date Filing Date
SG768/92A SG76892G (en) 1986-11-28 1992-07-28 Phospholipid composition

Country Status (10)

Country Link
US (2) US5429823A (xx)
EP (1) EP0293465B1 (xx)
JP (1) JP2517094B2 (xx)
KR (1) KR900007831B1 (xx)
AU (1) AU599456B2 (xx)
CA (1) CA1308025C (xx)
DE (1) DE3777640D1 (xx)
NZ (1) NZ222716A (xx)
SG (1) SG76892G (xx)
WO (1) WO1988003797A1 (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4107153A1 (de) * 1991-03-06 1992-09-10 Gregor Cevc Praeparat zur wirkstoffapplikation in kleinsttroepfchenform
DE4107152C2 (de) * 1991-03-06 1994-03-24 Gregor Cevc Präparate zur nichtinvasiven Verabreichung von Antidiabetica
WO1994022430A1 (en) * 1993-04-02 1994-10-13 The Liposome Company, Inc. Method of producing liposomes
US20020048596A1 (en) * 1994-12-30 2002-04-25 Gregor Cevc Preparation for the transport of an active substance across barriers
US6210707B1 (en) * 1996-11-12 2001-04-03 The Regents Of The University Of California Methods of forming protein-linked lipidic microparticles, and compositions thereof
AU729655B2 (en) * 1996-11-12 2001-02-08 Regents Of The University Of California, The Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery
WO2000012071A2 (de) * 1998-08-29 2000-03-09 Miklos Ghyczy Pharmazeutisches und/oder diätetisches produkt
JP4838936B2 (ja) * 1998-10-23 2011-12-14 イデア アクチェンゲゼルシャフト 装荷量を改善しおよび脱/会合速度を制御可能とするための、巨大分子と複合凝集体との会合体を開発し、テストし、かつ利用する方法
EP1031347B1 (en) 1999-01-27 2002-04-17 Idea Ag Transnasal transport/immunisation with highly adaptable carriers
EP1031346B1 (en) 1999-01-27 2002-05-02 Idea Ag Noninvasive vaccination through the skin
US6613352B2 (en) 1999-04-13 2003-09-02 Universite De Montreal Low-rigidity liposomal formulation
AU770395B2 (en) * 1999-11-17 2004-02-19 Boston Scientific Limited Microfabricated devices for the delivery of molecules into a carrier fluid
US7473432B2 (en) * 2002-10-11 2009-01-06 Idea Ag NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
JP2008519784A (ja) * 2004-11-12 2008-06-12 イデア アクチェンゲゼルシャフト 皮膚状態の治療における拡張表面凝集体
CN100500676C (zh) * 2006-04-17 2009-06-17 江南大学 一种不含溶血磷脂的高纯大豆磷脂酰胆碱的制备方法
US9445975B2 (en) 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
US20130066064A1 (en) * 2010-05-20 2013-03-14 Glaxosmithkline Biologicals S.A, Novel process
MY161428A (en) 2012-09-12 2017-04-14 Sime Darby Malaysia Berhad Extracting Lecithin From Palm Agro-Waste
US9353137B2 (en) * 2014-02-07 2016-05-31 Ghassem Amoabediny Method for separation and purification of phosphatidylcholine employing magnetic nanoparticles and compositions so produced
CA3029419A1 (en) 2016-06-29 2018-01-04 Machavert Pharmaceuticals Llc Phospholipid compositions
CN108101938B (zh) * 2017-11-17 2021-05-11 扬子江药业集团有限公司 一种高纯度多烯磷脂酰胆碱的制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2390528A (en) * 1940-05-13 1945-12-11 Pittsburgh Plate Glass Co Extraction of phosphatides, free fatty acids, and the like from glyceride oils
US2727046A (en) * 1951-12-17 1955-12-13 Charles R Scholfield Purification of phosphatides
US2801255A (en) * 1955-06-17 1957-07-30 Charles R Scholfield Method of purifying phosphatidyl ethanolamine
GB933814A (en) * 1959-05-12 1963-08-14 Unilever Ltd Improvements in or relating to the purification of phosphatides
FR6256M (xx) * 1967-01-26 1968-08-19
US3869482A (en) * 1972-07-31 1975-03-04 Etapharm Chem Pharm Lab G M B Method of producing highly purified phosphatides
DE2718797B2 (de) * 1977-04-27 1979-10-04 A. Nattermann & Cie Gmbh, 5000 Koeln Verfahren zur Gewinnung von ölhaltigen hochgereinigten Phosphatidylcholinen
CH624011A5 (xx) * 1977-08-05 1981-07-15 Battelle Memorial Institute
JPS595263B2 (ja) * 1977-10-25 1984-02-03 キユーピー株式会社 卵黄燐脂質の製造法
US4705806A (en) * 1978-02-13 1987-11-10 Morton Jr Douglas R Prostacyclin analogs
US4157404A (en) * 1978-07-28 1979-06-05 Asahi Kasei Kogyo Kabushiki Kaisha Process for obtaining yolk lecithin from raw egg yolk
IT1111367B (it) * 1978-11-17 1986-01-13 Serono Ist Farm Processo per la preparazione estemporanea di liposomi e liposomi cosi' ottenuti
US4598051A (en) * 1980-03-12 1986-07-01 The Regents Of The University Of California Liposome conjugates and diagnostic methods therewith
DE3047011A1 (de) * 1980-12-13 1982-07-22 A. Nattermann & Cie GmbH, 5000 Köln Verfahren zur abtrennung von oel und/oder phosphatidylethanolamin aus diese enthaltenden alkoholloeslichen phosphatidylcholin-produkten
FR2521565B1 (fr) * 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
US4714571A (en) * 1984-02-13 1987-12-22 The Liposome Company, Inc. Process for purification of phospholipids
US4814111A (en) * 1984-02-13 1989-03-21 Air Products And Chemicals, Inc. Process for purification of phospholipids
JPS60231608A (ja) * 1984-04-28 1985-11-18 Terumo Corp 膜構造が強化されたリポソ−ム
JPS61353A (ja) * 1984-06-13 1986-01-06 テルモ株式会社 薬剤投与装置
GB8423436D0 (en) * 1984-09-17 1984-10-24 Riker Laboratories Inc Preparation of liposomes
DE3445950A1 (de) * 1984-12-17 1986-06-19 A. Nattermann & Cie GmbH, 5000 Köln Verfahren zur isolierung von lysophosphatidylcholin-freiem phosphatidylcholin aus ei-pulver

Also Published As

Publication number Publication date
AU599456B2 (en) 1990-07-19
DE3777640D1 (xx) 1992-04-23
EP0293465A1 (en) 1988-12-07
AU1156788A (en) 1988-06-16
US5783210A (en) 1998-07-21
NZ222716A (en) 1990-08-28
KR900007831B1 (ko) 1990-10-20
US5429823A (en) 1995-07-04
WO1988003797A1 (en) 1988-06-02
KR890700021A (ko) 1989-03-02
CA1308025C (en) 1992-09-29
EP0293465B1 (en) 1992-03-18
EP0293465A4 (en) 1988-11-28
JP2517094B2 (ja) 1996-07-24
JPH01501479A (ja) 1989-05-25

Similar Documents

Publication Publication Date Title
GB8615534D0 (en) Composition
GB8623459D0 (en) Composition
EP0158441A3 (en) Liposome-forming composition
GB8721936D0 (en) Composition
GB8724250D0 (en) Composition
SG76892G (en) Phospholipid composition
ZA88637B (en) Fire-resitant composition
EP0292963A3 (en) Fiber-treatment composition
GB2203336B (en) Composition
GB8714145D0 (en) Phtoresist composition
PH23749A (en) Composition
HUT51856A (en) Mollusquicid composition
GB8715191D0 (en) Composition
GB8721400D0 (en) Composition
EG18594A (en) Shampo composition
GB8612550D0 (en) Composition
GB8622124D0 (en) Composition
GB2186877B (en) Phospholipids
ZW23887A1 (en) Herbicide-antidote composition
GB8601048D0 (en) Compositions
JPS6460631A (en) Polyfluoroalkoxyphosphazene composition
HK71592A (en) Phospholipid composition
HUT46724A (en) Sprinkling-salt composition
GB8607048D0 (en) Composition
GB8518429D0 (en) Lipid composition